SCHEMBL15768694

SCHEMBL15768694

CC[C@@]1(C(=O)O)[C@@H](c2ccccc2)[C@@H]1c1ccccc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
CACNA1D Q01668 5/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
CACNA1F O60840 3/20 0.41
CACNA1S Q13698 3/20 0.41
CACNA1C Q13936 3/20 0.41
LMNA P02545 3/20 0.41
ABCC4 O15439 2/20 0.41
ABCB11 O95342 2/20 0.41
CYP1A2 P05177 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
OPRM1 P35372 2/20 0.41
SCN1A P35498 2/20 0.41
HTR2B P41595 2/20 0.41
KCNH2 Q12809 2/20 0.41
SCN5A Q14524 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15768692 1.00 ALDH1A1 (0.41) ALDH1A1CACNA1DKMT2AMAPTKDM4E
SCHEMBL12498139 1.00 ALDH1A1 (0.41) ALDH1A1CACNA1DKMT2AMAPTKDM4E
SCHEMBL12498987 0.82 LMNA (0.49) ALDH1A1CACNA1DKMT2AMAPTLMNA
SCHEMBL12498189 0.81 KMT2A (0.37) ALDH1A1KMT2AMAPTLMNAALOX12
SCHEMBL15768953 0.81 KMT2A (0.37) ALDH1A1KMT2AMAPTLMNAALOX12
SCHEMBL15768582 0.79 HDAC4 (0.42) KMT2ACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL12498918 0.79 HDAC4 (0.42) KMT2ACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL12499379 0.79 HDAC4 (0.44) ALDH1A1KMT2ALMNACYP1A2ADORA3
SCHEMBL15768826 0.79 HDAC4 (0.44) ALDH1A1KMT2ALMNACYP1A2ADORA3
SCHEMBL12498067 0.78 HDAC4 (0.43) ALDH1A1KMT2ALMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765054-B2 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2017-09-19 US disclosed
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF HDAC1, HDAC7, HDAC5 ALDH1A1 559/4885CACNA1D 4562/4885KMT2A 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.